Abstract Six new triorganotin complexes, [(R3Sn)2(O2CC5H3NS)2]n (R = Me: 1; n-Bu: 2), [(R3Sn)2(O2CC6H4S)2]n (R = Me: 3; n-Bu: 4), [(R3Sn)2(O2CCH2S)2]n (R = Me: 5; n-Bu: 6) have been obtained by the reaction of R3SnCl (R = Me, n-Bu)… Click to show full abstract
Abstract Six new triorganotin complexes, [(R3Sn)2(O2CC5H3NS)2]n (R = Me: 1; n-Bu: 2), [(R3Sn)2(O2CC6H4S)2]n (R = Me: 3; n-Bu: 4), [(R3Sn)2(O2CCH2S)2]n (R = Me: 5; n-Bu: 6) have been obtained by the reaction of R3SnCl (R = Me, n-Bu) with the corresponding dicarboxylate ligands (H2L1 = 6,6’-dithiodinicotinic acid, H2L2 = 2,2’-dithiodibenzoic acid, H2L3 = dithiodiglycolic acid). All the compounds were characterized by elemental analysis, IR, NMR, and X-ray crystallography. The structural analysis reveals that complexes 1–6 display various 2D metal-organic framework structures including wave-like, corrugated and double-layer, which is attributed to the twisting of the ligands around flexible S S bonds. Additionally, in vitro cytotoxic investigation of complexes 1–6 were also conducted by employing human cervix cell lines (HeLa) and human lung cancer cells (A549).
               
Click one of the above tabs to view related content.